Compare Stocks

The Trust's investment objectives are high current income and to return $9.851 per share (the original net asset value) to holders of common shares on or about October 31, 20222 ("Termination Date").

Metropolitan Health Networks, Inc. (Metropolitan) is primarily engaged in the business of operating the provider services network (PSN) through its wholly owned subsidiaries, Metcare of Florida, Inc. and Continucare Corporation (Continucare). The PSN provides and arranges for the provision of healthcare services to Medicare Advantage and Medicaid beneficiaries in the State of Florida. As of December 31, 2011, it operated the PSN through its 33 wholly owned primary care practices, a wholly owned oncology practice, and contracts with almost 450 independent primary care practices (each an IPA). As of December 31, 2011, the PSN operated in 18 Florida counties, including the Miami, Ft. Lauderdale, West Palm Beach, Tampa and Daytona metropolitan areas. In December 2012, Humana Inc acquired Metropolitan Health Networks, Inc.

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for cardiovascular interventions. The company operates in two segments, Medical and Industrial. The company provides advanced optical-based pressure guidewire (OptoWire), a guidewire used in the transcatheter aortic valve replacement procedure; and a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated in other medical devices. It also develops, manufactures, and markets medical products; and offers OPP-GD fiber optic differential pressure sensors and the OEC fiber optic extensometer sensors. The company serves life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and various other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. Opsens Inc. was formerly known as Capital DCB inc. and changed its name to OpSens Inc. in October 2006. The company was founded in 2003 and is headquartered in Québec, Canada. As of December 12, 2023, Opsens Inc. operates as a subsidiary of Haemonetics Corporation.